Literature DB >> 11501692

Moderators and mediators of long-term adherence to stimulant treatment in children with ADHD.

D Thiruchelvam1, A Charach, R J Schachar.   

Abstract

OBJECTIVE: To identify moderators and mediators of long-term adherence to stimulant medication in children with attention-deficit hyperactivity disorder (ADHD).
METHOD: Seventy-one children with ADHD were prescribed methylphenidate, followed prospectively on an annual basis for 3 years, and evaluated for adherence to stimulant treatment. The study occurred in Toronto between 1993 and 1997. Adherents were those who took methylphenidate, or another psychostimulant, for 5 or more days per week throughout the follow-up period, except for "drug holidays." Children who adhered at consecutive evaluations were compared with those who did not. Severity of ADHD, presence of oppositional defiant disorder/conduct disorder, learning difficulties, anxiety, age, family dysfunction, and socioeconomic adversity at baseline were investigated as moderators of adherence. Response to treatment at school, measured at 12 months, was investigated as a mediator of adherence.
RESULTS: Fifty-two percent of children adhered to stimulant treatment for 3 years. Absence of teacher-rated oppositional defiant disorder, more teacher-rated ADHD symptoms, and younger age at baseline predicted adherence.
CONCLUSIONS: Adherence to stimulant medications is a significant factor in the long-term treatment of children with ADHD.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11501692     DOI: 10.1097/00004583-200108000-00014

Source DB:  PubMed          Journal:  J Am Acad Child Adolesc Psychiatry        ISSN: 0890-8567            Impact factor:   8.829


  41 in total

1.  Adolescents' commitment to continuing psychotropic medication: a preliminary investigation of considerations, contradictions, and correlates.

Authors:  Tally Moses
Journal:  Child Psychiatry Hum Dev       Date:  2011-02

2.  Extended-release medications for children and adolescents with attention-deficit hyperactivity disorder.

Authors:  M Feldman; S Bélanger
Journal:  Paediatr Child Health       Date:  2009-11       Impact factor: 2.253

3.  Medication refusal in children with oppositional defiant disorder or conduct disorder and comorbid attention-deficit/hyperactivity disorder: medication history and clinical correlates.

Authors:  Mark Demidovich; David J Kolko; Oscar G Bukstein; Jonathan Hart
Journal:  J Child Adolesc Psychopharmacol       Date:  2011-02-02       Impact factor: 2.576

4.  Predictors of Medication Continuity in Children With ADHD.

Authors:  William B Brinkman; Heidi Sucharew; Jessica Hartl Majcher; Jeffery N Epstein
Journal:  Pediatrics       Date:  2018-06       Impact factor: 7.124

5.  Long Acting Risperidone in an Adolescent with Conduct Disorder: A Case Report.

Authors:  Mustafa Deniz Tutkunkardaş; Osman Abali
Journal:  Psychopharmacol Bull       Date:  2011-09-15

6.  To adhere or not, and what we can do to help.

Authors:  F McNicholas
Journal:  Eur Child Adolesc Psychiatry       Date:  2012-09-04       Impact factor: 4.785

7.  Stimulant treatment of ADHD and cigarette smoking: a meta-analysis.

Authors:  Erin N Schoenfelder; Stephen V Faraone; Scott H Kollins
Journal:  Pediatrics       Date:  2014-05-12       Impact factor: 7.124

8.  Treatment of attention deficit hyperactivity disorder in children. Predictors of treatment outcome.

Authors:  Saskia van der Oord; P J M Prins; J Oosterlaan; P M G Emmelkamp
Journal:  Eur Child Adolesc Psychiatry       Date:  2007-09-14       Impact factor: 4.785

9.  Dopamine transporter genotype and stimulant side effect factors in youth diagnosed with attention-deficit/hyperactivity disorder.

Authors:  Reut Gruber; Ridha Joober; Natalie Grizenko; Bennett L Leventhal; Edwin H Cook; Mark A Stein
Journal:  J Child Adolesc Psychopharmacol       Date:  2009-06       Impact factor: 2.576

10.  Documenting adherence to psychostimulants in children with ADHD.

Authors:  Alice Charach; Amy Gajaria; Anna Skyba; Shirley Chen
Journal:  J Can Acad Child Adolesc Psychiatry       Date:  2008-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.